Lymphangioleiomyomatosis Clinical Trials

43 clinical trials for Lymphangioleiomyomatosis across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of the Disease Process of Lymphangioleiomyomatosis — RECRUITING
• Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis — RECRUITING · PHASE1
• TSC Biosample Repository and Natural History Database — RECRUITING
• Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry) — RECRUITING
• Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM) — RECRUITING · PHASE1
• Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex — RECRUITING
• National Lymphangioleiomyomatosis Registry, France — RECRUITING
• Safety and Durability of Sirolimus for Treatment of LAM — RECRUITING
• Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases — RECRUITING
• A randomised, double blind, placebo controlled trial of doxycycline in lymphangioleiomyomatosis. — COMPLETED · PHASE4
• An exploratory, open label, non-randomized, within-patient multiple dose-escalation safety, tolerability, PK and efficacy trial of RAD001 (everolimus) in patients with Lymphangioleiomyomatosis. — COMPLETED · PHASE2
• Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease — TERMINATED · PHASE1
• Discovery of Sirolimus Sensitive Biomarkers in Blood — COMPLETED · PHASE2
• Feasibility of [11C]Acetate-PET in LAM and TSC — ACTIVE_NOT_RECRUITING · PHASE1
• Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial — ACTIVE_NOT_RECRUITING · PHASE3
• Letrozole for Lymphangioleiomyomatosis — COMPLETED · PHASE2
• Efficacy and Safety of Sirolimus in LAM — COMPLETED · PHASE3
• Lymphangioleiomyomatosis, a Study on Cathepsin K — COMPLETED
• Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) — TERMINATED
• Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial — COMPLETED · PHASE2
• A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) — COMPLETED · PHASE2
• Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma — COMPLETED
• Effect of Loratadine in Lymphangioleiomyomatosis — OTHER · PHASE2
• COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC — COMPLETED · PHASE2
• Characterizing LAM With 11C-Choline PET/CT — OTHER · PHASE1
• Glutamine PET Imaging in LAM — COMPLETED · PHASE1
• Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases — COMPLETED
• Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis — OTHER · NA
• A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis — COMPLETED · PHASE2
• Safety of Simvastatin in LAM and TSC — COMPLETED · PHASE1
• LAM Pilot Study With Imatinib Mesylate — COMPLETED · PHASE1
• Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM) — COMPLETED
• Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women — COMPLETED
• Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis — COMPLETED · PHASE1
• The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients — COMPLETED · NA
• Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) — COMPLETED · PHASE3
• Pulmonary Rehabilitation in Lymphangioleiomyomatosis — COMPLETED · NA
• Doxycycline In Lymphangioleiomyomatosis (LAM) — COMPLETED · PHASE4
• RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM — COMPLETED · PHASE1
• Pulmonary Hypertension in Lymphangioleiomyomatosis — COMPLETED
• Treatment With Octreotide in Patients With Lymphangioleiomyomatosis — COMPLETED · PHASE2
• Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM — OTHER · PHASE2
• Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM — COMPLETED · PHASE2

Refine this search